0 CHECKOUT

PRODUCT FILTERS

REGION

46
20
19
18
18

COUNTRY

17
7
5
2
1

CATEGORIES

  • 49
  • 44
  • 17
  • 12
  • 8
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

19
33
97
152

PUBLISHED

2
9
27
152

PRODUCT TYPE

145
4
1
1
1

Search for: "Biocon: Biosimilars Company Analysis"

152 Products

Biocon Limited - Product Pipeline Review - 2013

Biocon Limited - Product Pipeline Review - 2013 Summary “Biocon Limited - Product Pipeline Review - 2013” provides data on the Biocon Limited’s research and development focus. The report includes...

Published:  December 2013
Price:  From

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

Published:  July 2012
Price:  From

Global & USA BioSimilar Market Analysis to 2021

BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons,...

Published:  August 2015
Price:  From

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From

Tapping Biosimilar Opportunities

Tapping biosimilar opportunities A Follow on biologic (FOB) or Biosimilar, as commonly known, has been one of the most widely discussed topics in the world of pharma in the last few years The approaching...

Published:  September 2011
Price:  From

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

Published:  August 2012
Price:  From

Global Cancer Biosimilars Market Opportunity Outlook

Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available...

Published:  June 2015
Price:  From

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research,...

Published:  June 2012
Price:  From

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

Published:  December 2009
Price:  From

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

Published:  March 2014
Price:  From
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  February 2015
Price:  From

Biocon Limited - Product Pipeline Review - 2014

Biocon Limited - Product Pipeline Review - 2014 Summary This, ‘Biocon Limited - Product Pipeline Review - 2014’, provides an overview of the Biocon Limited’s pharmaceutical research and development...

Published:  July 2014
Price:  From

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

Published:  November 2012
Price:  From

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

Published:  September 2013
Price:  From

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

Published:  April 2011
Price:  From

Biocon Limited - Product Pipeline Review - 2012

Biocon Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - 2012” provides data on the Biocon Limited’s research...

Published:  August 2012
Price:  From

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

Published:  April 2012
Price:  From

Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application - Global Forecast to 2020.

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application...

Published:  July 2015
Price:  From

Biosimilar Index: Tracking the Global Biosimilar Pipeline

NOTE: The format of this Biosimilar Index is Excel & PowerPoint Biosimilar Index answers your questions, such as - There are 15 biosimilar and non-comparable biologic (NCB) versions of bevacizumab (Avastin;...

Published:  March 2014
Price: 
Biosimilar Index: Tracking the Global Biosimilar Pipeline Biosimilar Index: Tracking the Global Biosimilar Pipeline - Product Thumbnail Image

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  October 2012
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.